Preventive pharmacotherapy in type 2 diabetes mellitus.

about

Effect of Hypericum perforatum L. extract on insulin resistance and lipid metabolic disorder in high-fat-diet induced obese mice Effect of current glycemic control on qualitative body composition in sedentary ambulatory Type 2 diabetics.Efficacy of voglibose in type 2 diabetes.

P2860

Q35004422-F483F2F9-7EA6-47A0-ADB3-09D83F6BB2BE Q36876717-F66B4129-A7CC-4CBF-B50C-4236D855F08D Q38209518-D429C330-F968-40C3-95C1-C795D515166B

P2860

Preventive pharmacotherapy in type 2 diabetes mellitus.

Item

http://www.wikidata.org/entity/Q35686344

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Preventive pharmacotherapy in type 2 diabetes mellitus.

@ast

Preventive pharmacotherapy in type 2 diabetes mellitus.

@en

type

Item

label

Preventive pharmacotherapy in type 2 diabetes mellitus.

@ast

Preventive pharmacotherapy in type 2 diabetes mellitus.

@en

prefLabel

Preventive pharmacotherapy in type 2 diabetes mellitus.

@ast

Preventive pharmacotherapy in type 2 diabetes mellitus.

@en

P1476

Preventive pharmacotherapy in type 2 diabetes mellitus.

@en

P2093

Ambika Gopalkrishnan Unnikrishnan

http://www.w3.org/2001/XMLSchema#string

Neeraj Choudhary

http://www.w3.org/2001/XMLSchema#string

T P Ajish

http://www.w3.org/2001/XMLSchema#string

P2860

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

Global and societal implications of the diabetes epidemic

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

Demographic and epidemiologic transition in the developing world: role of albuminuria in the early diagnosis and prevention of renal and cardiovascular disease.

Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study.

P304

33-43

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/2230-8210.91183

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sanjay Kalra

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22276251

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

pharmacotherapy

P932

3263195

http://www.w3.org/2001/XMLSchema#string

Preventive pharmacotherapy in type 2 diabetes mellitus.

about

P2860

P2860

Preventive pharmacotherapy in type 2 diabetes mellitus.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932